Cerus (CERS) vs Tactile Systems Technology (TCMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Tactile Systems Technology (TCMD) has outperformed Cerus (CERS) over the past year, gaining 48.4% versus a gain of 43.1%. Over five years, TCMD leads with a -38.0% price change compared with -62.6% for CERS. Tactile Systems Technology is the larger company by market cap ($498.8 million vs $461.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | TCMD |
|---|---|---|
| Share price | $2.29 | $22.02 |
| Market cap | $461.49M | $498.80M |
| 1-day change | -2.14% | -0.77% |
| YTD return | +11.17% | -24.07% |
| 1-year return | +43.13% | +48.38% |
| 5-year return | -62.58% | -37.97% |
| P/E ratio (TTM) | — | 20.39 |
| Forward P/E | — | 15.13 |
| EPS (TTM) | $-0.03 | $1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $37.77 |
| 52-week low | $1.38 | $14.00 |
| Distance from 52-week high | -34.01% | -41.70% |
| Analyst consensus | none | none |
| Avg. price target upside | +124.02% | +77.11% |
| Average volume | 2.15M | 294.17K |
| Shares outstanding | 201.52M | 22.65M |
| Employees | 261 | 1,086 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Healthcare · Medical Devices · 261 employees
About Tactile Systems Technology
TCMD stock →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Healthcare · Medical Devices · 1,086 employees
CERS vs TCMD FAQ
Which is bigger, Cerus or Tactile Systems Technology?
Tactile Systems Technology (TCMD) is larger, with a market capitalization of $498.80M compared with $461.49M for Cerus (CERS).
Which stock has performed better over the past year, CERS or TCMD?
TCMD returned +48.38% over the past 12 months, compared with +43.13% for CERS (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and Tactile Systems Technology in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.